Precision Medicine Group (PMG), a specialised services company that supports next generation approaches to drug development and commercialisation, announced on Thursday that it has acquired Project Farma, a patient-focused bioengineering services company that supports life science innovators in the manufacturing and scale-up of advanced therapies.

This transaction is intended to add Project Farma's expertise to Precision's suite of end-to-end cell and gene therapy capabilities to help development and commercialisation.

Project Farma is headed by executive leaders Anshul Mangal, John Khoury and Tony Khoury. It has led over a dozen manufacturing facility builds with capital investments of more than USD1bn. It will be part of Precision for Medicine, PMG's research and development services unit.